Annovis Bio Inc (NY: ANVS )
7.260
+1.260
(+21.00%)
Streaming Delayed Price
Updated: 12:52 PM EDT, May 31, 2024
Add to My Watchlist
All News about Annovis Bio Inc
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
January 25, 2022
Via Newsfile
Exposures
Product Safety
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims
October 13, 2021
From Jakubowitz Law
Via AccessWire
Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|